Will Japan be able to reduce its generic drug prices?
Japan | Analysis | By BioSpectrum Bureau | 2 Comment | 21 May, 2013
The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the ...Read more
Life Tech signs agreement with iPS Academia Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2012
Singapore: Life Technologies has signed a non-exclusive agreement with iPS Academia Japan for its induced pluripotent st...Read more
Nagoya scientists discover new molecules that change circadian rhythm
Japan | News | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2015
A team of chemists and biologists at the Institute of Transformative Bio-Molecules (ITbM), Nagoya University, Japan, hav...Read more
BioDiem protozoan drug to get Japanese patent
Japan | News | By BioSpectrum Bureau | 0 Comment | 27 May, 2013
Singapore: Australian infectious disease therapy and vaccine development company, BioDiem, has received allowance of Jap...Read more
Eisai, Nihon Medi-Physics to work on dementia intervention
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 Apr, 2015
Japanese pharmaceutical giant Eisai Co. Ltd. and Nihon Medi-Physics Co. Ltd. have entered into a collaboration agreement...Read more
R-Tech Ueno acquires right to develop Santen Pharma's ophthalmic solution
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 Apr, 2015
R-Tech Ueno Ltd, headquartered in Tokyo, has acquired the right to develop and commercialize DE-105 from Santen Pharmace...Read more
French firm successfully completes Ph I trial of diabetes drug in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 May, 2015
Singapore: French biopharmaceutical company, Poxel, an innovative drug developer for type 2 diabetes, has succesfully co...Read more
Tarceva tablets with Nexavar show no improvement
Japan | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2012
Singapore: A phase III trial evaluating the efficacy and safety of the addition of Tarceva (erlotinib) tablets to Nexava...Read more
Mylan signs a settlement agreement with OSI Pharma
Japan | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2013
Singapore: US generics major Mylan has entered into a settlement agreement with OSI Pharmaceuticals, a subsidiary of Jap...Read more
Sale of wound care devices spurs in Asia-Pacific: Frost & Sullivan analysis report
Japan | News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2013
Singapore: Advanced wound care and modern wound closure products are gaining an edge over traditional wound dressings in...Read more
Biogen inks autoimmune deal with Mitsubhishi Tanabe pharma
Japan | News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2015
Singapore: US-based Biogen, a leading developer of therapies for neurodegenerative diseases has inked a pact with Japan'...Read more
Japan approves Daiichi Sankyo's Cravit Injections
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 Sep, 2015
Tokyo: Daiichi Sankyo Company, Limited has obtained approval for partial changes concerning a supplementary indication ...Read more
Synageva BioPharma seeks approval for Kanuma in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2015
NASDAQ-listed Synageva BioPharma Corp. has submitted the New Drug Application (NDA) for Kanuma (sebelipase alfa) to the ...Read more
Bayer's thrombosis drug approved in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 Sep, 2015
Tokyo: Bayer HealthCare has announced that the company has received approval in Japan for its oral Factor Xa inhibitor X...Read more
Matt Kerr: Tough task ahead for APAC HR managers
Japan | Opinion | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013
With rapid growth of life sciences industry in Asia, we have seen many success stories over the last decade. However, an...Read more
Takeda transfers HPV vaccine license to Japanese firm
Japan | News | By BioSpectrum Bureau | 0 Comment | 12 Mar, 2015
Singapore: Takeda Pharmaceutical has transferred its license agreement with the Japan Health Sciences Foundation (HS Fou...Read more
Medtech Partnering Forum 2015 to be held in Tokyo
Japan | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2015
Singapore: EBD Group, organizer of leading international life science partnering conferences, has announced Medtech Part...Read more
Hyperion to succeed Santen's anti-rheumatic business
Japan | News | By BioSpectrum Bureau | 0 Comment | 13 May, 2015
Singapore: Japanese pharmaceutical major Santen Pharmaceutical has decided to sign an agreement with Showa Yakuhin Kakou...Read more